|
Putcharoen, Opass; Lee, Sun Hee; Henrich, Timothy J et al. (2012) HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug. J Virol 86:1119-28
|
|
Tsibris, Athe M N; Hu, Zixin; Paredes, Roger et al. (2012) Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures. J Virol 86:6416-26
|
|
Kitchen, Christina M R; Kroll, Jing; Kuritzkes, Daniel R et al. (2009) Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment. Comput Stat Data Anal 53:766-775
|
|
Hosoya, Noriaki; Su, Zhaohui; Wilkin, Timothy et al. (2009) Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions. J Clin Microbiol 47:2604-6
|
|
Marconi, Vincent; Bonhoeffer, Sebastian; Paredes, Roger et al. (2008) Viral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide. J Acquir Immune Defic Syndr 48:572-6
|
|
Price, Richard W; Parham, Robin; Kroll, Jing Lu et al. (2008) Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin. Antivir Ther 13:369-74
|
|
Beatty, George; Hunt, Peter; Smith, Anna et al. (2006) A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide. Antivir Ther 11:315-9
|
|
Lu, Jing; Deeks, Steven G; Hoh, Rebecca et al. (2006) Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis. J Acquir Immune Defic Syndr 43:60-4
|
|
Lu, Jing; Sista, Prakash; Giguel, Francoise et al. (2004) Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20). J Virol 78:4628-37
|
